TO: LINDA REICH, CITY MANAGER
FROM: KEVIN MENSEN, CHIEF OF POLICE
SUBJECT
title
Adoption of Resolution No. 2025-054 authorizing approval of Opioid Settlement Agreements with Pharmacy Chains Alvogen, Amneal, Apotex, Hikma, Indivior, Mylan, Sun, and Zydus.
end
RECOMMENDATION
Adoption of Resolution 2025-054 authorizing the City to enter into Settlement Agreements with Alvogen, Amneal, Apotex, Hikma, Indivior, Mylan, Sun, and Zydus to resolve lawsuits accusing pharmacy chains of mishandling opioid pain drugs, agree to the terms of the related State-Subdivision Agreement, and authorize entry into the related State-Subdivision Agreement with the Attorney General.
body
FISCAL IMPACT
The actual amount the City will receive (and pass through to the County) from the settlement depends on a variety of factors, including the number of California municipalities participating.
CITY OF CHINO MISSION / VISION / VALUES / STRATEGIC ISSUES
The recommendation detailed above further the City's values and strategic issues that serve as key pillars on which identified priorities, goals, and action plans are built, by fostering:
* Positive City Image
* Financial Stability
* Responsible Long-Range Planning
Revenue: Click or tap here to enter text.
Expenditure:
Transfer In: Click or tap here to enter text.
Transfer Out: Click or tap here to enter text.
BACKGROUND
A new group of national opioid settlements totaling up to $720 million has been reached with eight additional opioid manufacturers. These settlements are part of broader nationwide litigation efforts to hold opioid manufacturers accountable for their role in the opioid epidemic. These settlements are separate from the Purdue/Sackler bankruptcy settlement and prior agreements with major distributors and retailers.
Each participating jurisdiction must affirmatively opt in by October 8, 2025, to be eligible for any share of the funding. Subdivisions do not need to have joined previous settlements to participate in ...
Click here for full text